Profund Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,007
| Closed | -$714K | – | 1097 |
|
|
2023
Q2 | $714K | Buy |
7,007
+2,401
| +52% | +$245K | 0.04% | 403 |
|
|
2023
Q1 | $419K | Buy |
+4,606
| New | +$419K | 0.03% | 564 |
|
|
2021
Q4 | – | Sell |
-2,532
| Closed | -$255K | – | 1419 |
|
|
2021
Q3 | $255K | Sell |
2,532
-231
| -8% | -$23.3K | 0.01% | 1077 |
|
|
2021
Q2 | $391K | Buy |
+2,763
| New | +$391K | 0.01% | 843 |
|
|
2021
Q1 | – | Sell |
-1,825
| Closed | -$226K | – | 1372 |
|
|
2020
Q4 | $226K | Buy |
+1,825
| New | +$226K | 0.01% | 1028 |
|
|
2020
Q3 | – | Sell |
-1,960
| Closed | -$306K | – | 1015 |
|
|
2020
Q2 | $306K | Sell |
1,960
-127
| -6% | -$19.8K | 0.02% | 590 |
|
|
2020
Q1 | $301K | Sell |
2,087
-221
| -10% | -$31.9K | 0.02% | 496 |
|
|
2019
Q4 | $472K | Buy |
+2,308
| New | +$472K | 0.02% | 642 |
|
|
2018
Q4 | – | Sell |
-3,590
| Closed | -$294K | – | 1473 |
|
|
2018
Q3 | $294K | Buy |
+3,590
| New | +$294K | 0.01% | 1215 |
|